Literature DB >> 10541481

Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice.

J I Alak1, B W Wolf, E G Mdurvwa, G E Pimentel-Smith, S Kolavala, H Abdelrahman, V Suppiramaniam.   

Abstract

The effect of L. acidophilus supplementation to reduce fecal shedding of Cryptosporidium parvum oocysts was compared to L. reuteri using C57BL/6 female mice immunosuppressed by murine leukemia virus (strain LP-BM5) inoculation. After 12 weeks post LP-BM5 inoculation, 15 immunosuppressed mice each were randomly assinged to one of the following treatment groups: historical control (group A), LP-BM5 control (group B), C. parvum (group C), L. reuteri plus C. parvum (group D) or L. acidophilus plus C. parvum (group E). Mice were pre-fed the L. reuteri or L. acidophilus bacteria strains daily for 13 days, challenged with C. parvum oocysts and thereafter fed the specified Lactobacillus regimens daily during the experimental period. Animals supplemented with L. reuteri shed fewer (p<0.05) oocysts on day-7 post C. parvum challenge compared to controls. Mice supplemented with L. acidophilus also shed fewer (p<0.05) oocysts on days 7 and 14 post-challenge compared to controls. Overall, Lactobacillus supplementation reduced C. parvum shedding in the feces but failed to suppress the production of T-helper type 2 cytokines [interleukin-4 (IL-4), IL-8)] which are associated with immunosuppression. Additionally, Lactobacillus supplementation did not restore T-helper type 1 cytokines (interleukin-2 (IL-2) and gamma interferon (IFN-gamma), which are required for recovery from parasitic infections. Altered T-helper types 1 and 2 cytokine production as a consequence of immunodysfunction permitted the development of persistent cryptosporidiosis while mice with intact immune system were refractory to infection with C. parvum. Reduction in shedding of oocysts observed in the Lactobacillus supplemented mice during deminished IL-2 and IFN-gamma production may be mediated by factors released into the intestinal lumen by the Lactobacillus and possibly other host cellular mechanisms. These observations suggest that L. reuteri or L. acidophilus can reduce C. parvum parasite burdens in the intestinal epithelium during cryptosporidiosis and may serve potential benefits as probiotics for host resistance to intestinal parasitic infections. L. acidophilus was more efficacious in reducing fecal shedding than L. reuteri and therefore may also have implication in the therapy of cryptosporidiosis during immunosuppressive states including human AIDS.

Entities:  

Mesh:

Year:  1999        PMID: 10541481

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  14 in total

1.  Fecal Indole as a Biomarker of Susceptibility to Cryptosporidium Infection.

Authors:  Cynthia L Chappell; Charles Darkoh; Lawrence Shimmin; Naveed Farhana; Do-Kyun Kim; Pablo C Okhuysen; James Hixson
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

2.  Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial.

Authors:  Kulandaipalayam N C Sindhu; Thuppal V Sowmyanarayanan; Anu Paul; Sudhir Babji; Sitara S R Ajjampur; Sophia Priyadarshini; Rajiv Sarkar; K A Balasubramanian; Christine A Wanke; Honorine D Ward; Gagandeep Kang
Journal:  Clin Infect Dis       Date:  2014-02-05       Impact factor: 9.079

3.  Experimental study of the effects of probiotics on Cryptosporidium parvum infection in neonatal rats.

Authors:  Juliette Guitard; Jean Menotti; Allison Desveaux; Parissa Alimardani; Raphaël Porcher; Francis Derouin; Nathalie Kapel
Journal:  Parasitol Res       Date:  2006-04-13       Impact factor: 2.289

4.  Insights into the Mechanisms of Lactobacillus acidophilus Activity against Entamoeba histolytica by Using Thiol Redox Proteomics.

Authors:  Lotem Sarid; Eva Zanditenas; Jun Ye; Meirav Trebicz-Geffen; Serge Ankri
Journal:  Antioxidants (Basel)       Date:  2022-04-22

5.  Effect of Caging on Cryptosporidium parvum Proliferation in Mice.

Authors:  Hannah N Creasey; Wen Zhang; Giovanni Widmer
Journal:  Microorganisms       Date:  2022-06-17

6.  The Effects of Commercially Available Syzygium aromaticum, Anethum graveolens, Lactobacillus acidophilus LB, and Zinc as Alternatives Therapy in Experimental Mice Challenged with Cryptosporidium parvum.

Authors:  Mona Gaber; Lamia Ahmed A Galal; Haiam Mohamed Mahmoud Farrag; Dalia M Badary; Samia S Alkhalil; Nahed Elossily
Journal:  Infect Drug Resist       Date:  2022-01-20       Impact factor: 4.177

7.  Effects of Enterococcus faecalis CECT 7121 on Cryptosporidium parvum infection in mice.

Authors:  Valeria F Del Coco; Mónica D Sparo; Alicia Sidoti; Mónica Santín; Juan Angel Basualdo; María Alejandra Córdoba
Journal:  Parasitol Res       Date:  2016-05-19       Impact factor: 2.289

8.  Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens.

Authors:  Jennifer K Spinler; Malai Taweechotipatr; Cheryl L Rognerud; Ching N Ou; Somying Tumwasorn; James Versalovic
Journal:  Anaerobe       Date:  2008-02-29       Impact factor: 3.331

9.  Probiotics for the control of parasites: an overview.

Authors:  Marie-Agnès Travers; Isabelle Florent; Linda Kohl; Philippe Grellier
Journal:  J Parasitol Res       Date:  2011-09-28

Review 10.  Modulating the Gut Micro-Environment in the Treatment of Intestinal Parasites.

Authors:  Luis Vitetta; Emma Tali Saltzman; Tessa Nikov; Isabelle Ibrahim; Sean Hall
Journal:  J Clin Med       Date:  2016-11-16       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.